Merck's Ebola vaccine helps combat deadly outbreak in the Congo as the virus spreads
July 10, 2019 at 07:00 AM EDT
An unlicensed vaccine made by Merck was approved for use a week after the DRC declared the Ebola outbreak in August.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.